Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Neuroimmunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.JNEUROIM.2004.08.011PMID 15589038
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Minocycline Treatment Reduces Delayed Oligodendrocyte Death, Attenuates Axonal Dieback, and Improves Functional Outcome after Spinal Cord Injury

  2004cited by this paper
• Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion

  2004cited by this paper
• Inflammation and remyelination in the central nervous system: a tale of two systems.

  2004cited by this paper
• Suppression of activated microglia promotes survival and function of transplanted oligodendroglial progenitors

  2003cited by this paper
• Functional Genomic Analysis of Remyelination Reveals Importance of Inflammation in Oligodendrocyte Regeneration

  2003cited by this paper
• Complement-receptor-3 and scavenger-receptor-AI/II mediated myelin phagocytosis in microglia and macrophages.

  2003cited by this paper
• Matrix Metalloproteinase-9 Facilitates Remyelination in Part by Processing the Inhibitory NG2 Proteoglycan

  2003cited by this paper
• Efficient central nervous system remyelination requires T cells

  2003cited by this paper
• Why does remyelination fail in multiple sclerosis?

  2002cited by this paper
• Inflammation in multiple sclerosis: the good, the bad, and the complex.

  2002cited by this paper
• Microglia as neuroprotective, immunocompetent cells of the CNS

  2002cited by this paper
• Microglial activation by purines and pyrimidines

  2002cited by this paper
• Inhibition of autoimmune encephalomyelitis by a tetracycline

  2002cited by this paper
• Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis.

  2002cited by this paper
• Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells.

  2002cited by this paper
• The Age-Related Decrease in CNS Remyelination Efficiency Is Attributable to an Impairment of Both Oligodendrocyte Progenitor Recruitment and Differentiation

  2002cited by this paper
• Interleukin-1β Promotes Repair of the CNS

  2001cited by this paper
• Minocycline, a Tetracycline Derivative, Is Neuroprotective against Excitotoxicity by Inhibiting Activation and Proliferation of Microglia

  2001cited by this paper
• Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin‐induced demyelination

  2001cited by this paper
• TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination.

  2001cited by this paper
• Interleukin-1beta promotes repair of the CNS.

  2001cited by this paper
• TNFα promotes proliferation of oligodendrocyte progenitors and remyelination

  2001influential reference
• Delayed changes in growth factor gene expression during slow remyelination in the CNS of aged rats.

  2000cited by this paper
• Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination

  2000cited by this paper
• Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti‐galactocerebroside: A comparative study

  1999cited by this paper
• A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window.

  1999cited by this paper
• Defective oligodendrocyte development and severe hypomyelination in PDGF-A knockout mice.

  1999cited by this paper
• Matrix Metalloproteinase-9/Gelatinase B Is Required for Process Outgrowth by Oligodendrocytes

  1999cited by this paper
• Absence of spontaneous central nervous system remyelination in class II-deficient mice infected with Theiler's virus.

  1999cited by this paper
• Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin‐induced CNS demyelination

  1999cited by this paper
• Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque.

  1998cited by this paper
• Indictment of the microglia as the villain in multiple sclerosis

  1997cited by this paper
• The gelatinase inhibitory activity of tetracyclines and chemically modified tetracycline analogues as measured by a novel microtiter assay for inhibitors.

  1996cited by this paper
• Mechanisms of Immune Injury in Multiple Sclerosis

  1996cited by this paper
• A novel mechanism of action of tetracyclines: effects on nitric oxide synthases.

  1996cited by this paper
• The tetracycline derivative minocycline differentially affects cytokine production by monocytes and T lymphocytes

  1996cited by this paper
• A developmental analysis of oligodendroglial integrins in primary cells: changes in alpha v-associated beta subunits during differentiation.

  1994cited by this paper
• Multiple Sclerosis: Remyelination in Acute Lesions

  1993cited by this paper
• DELAYED REMYELINATION IN RAT SPINAL CORD FOLLOWING ETHIDIUM BROMIDE INJECTION

  1986cited by this paper
• Tetracyclines inhibit tissue collagenase activity. A new mechanism in the treatment of periodontal disease.

  1984cited by this paper
• Tetracyclines inhibit tissue collagenase activity. A new mechanism in the treatment of periodontal disease.

  1984cited by this paper
• Chronic demyelination inhibits remyelination in the central nervous system. An analysis of contributing factors.

  1980cited by this paper
• Chronic demyelination inhibits remyelination in the central nervous system. An analysis of contributing factors.

  1980cited by this paper

• Development of a Human Preclinical Platform for the Identification of Neuroprotective Compounds

  2025cites this paper
• Innate Immunity in the Pathogenesis of Selected Autoimmune Neurological Diseases

  2025cites this paper
• Oligodendrocytes interactions with glial cells and neurons in demyelinating disease

  2025cites this paper
• Analysis of the Pro-Inflammatory Mechanisms of Gut Microbiota Metabolites in Inducing Alzheimer’s Disease

  2025cites this paper
• Significant oligodendrocyte progenitor and microglial cell death is a feature of remyelination following toxin-induced experimental demyelination

  2024cites this paper
• Beyond nimodipine: advanced neuroprotection strategies for aneurysmal subarachnoid hemorrhage vasospasm and delayed cerebral ischemia

  2024cites this paper
• Microglia in Glioblastomas: Molecular Insight and Immunotherapeutic Potential

  2024cites this paper
• Neuro-immune crosstalk in depressive symptoms of multiple sclerosis.

  2023cites this paper
• Innovative drug delivery strategies to the CNS for the treatment of multiple sclerosis.

  2023cites this paper
• The blood-brain barrier in aging and neurodegeneration

  2022cites this paper
• The multiple faces of extracellular vesicles released by microglia: Where are we 10 years after?

  2022cites this paper
• Treatment of Acute Spinal Cord Injury

  2022cites this paper
• Microglia as therapeutic targets for central nervous system remyelination.

  2022cites this paper
• Dynamics of Microglia Activation in the Ischemic Brain: Implications for Myelin Repair and Functional Recovery

  2022cites this paper
• Diversity and Function of Glial Cell Types in Multiple Sclerosis.

  2021cites this paper
• Microglia in Multiple Sclerosis: Friend or Foe?

  2020cites this paper
• Activated Microglia in the Rat Spinal Cord Following Peripheral Axon Injury Promote Glial and Neuronal Plasticity Which is Necessary for Long-Term Neuronal Survival

  2020cites this paper
• Astrocyte–Oligodendrocyte–Microglia Crosstalk in Astrocytopathies

  2020cites this paper
• Activated Microglia in the Rat Spinal Cord Following Peripheral Axon Injury Promote Glial and Neuronal Plasticity Which is Necessary for Long-Term Neuronal Survival

  2020cites this paper
• Neutrophils Return to Bloodstream Through the Brain Blood Vessel After Crosstalk With Microglia During LPS-Induced Neuroinflammation

  2020cites this paper
• The Impact of environmental and genetic insults on adult and developing brain oligodendrogenesis

  2020cites this paper
• Autophagy in Multiple Sclerosis: Two Sides of the Same Coin

  2020cites this paper
• The possible role of CREB‐BDNF signaling pathway in neuroprotective effects of minocycline against alcohol‐induced neurodegeneration: molecular and behavioral evidences

  2020cites this paper
• Blood-brain barrier integrity in the pathogenesis of Alzheimer's disease.

  2020cites this paper
• DTI Tract‐Based Quantitative Susceptibility Mapping: An Initial Feasibility Study to Investigate the Potential Role of Myelination in Brain Connectivity Change in Cerebral Palsy Patients During Autologous Cord Blood Cell Therapy Using a Rotationally‐Invariant Quantitative Measure

  2020cites this paper
• Platelet-Activating Factor Deteriorates Lysophosphatidylcholine-Induced Demyelination Via Its Receptor-Dependent and -Independent Effects

  2020cites this paper
• Csf1 Deficiency Dysregulates Glial Responses to Demyelination and Disturbs CNS White Matter Remyelination

  2019cites this paper
• The origin, fate, and contribution of macrophages to spinal cord injury pathology

  2019cites this paper
• The pro-remyelination properties of microglia in the central nervous system

  2019cites this paper
• Isolation and Preparation of Cells from Focal Remyelinating Central Nervous System Lesions for RNA Sequencing.

  2019cites this paper
• Minocycline impairs TNF-α-induced cell fusion of M13SV1-Cre cells with MDA-MB-435-pFDR1 cells by suppressing NF-κB transcriptional activity and its induction of target-gene expression of fusion-relevant factors

  2019cites this paper
• Interferon β-Mediated Protective Functions of Microglia in Central Nervous System Autoimmunity

  2019cites this paper
• Myelin status and oligodendrocyte lineage cells over time after spinal cord injury: What do we know and what still needs to be unwrapped?

  2019cites this paper
• Dynamic response of microglia/macrophage polarization following demyelination in mice

  2019cites this paper
• Purinergic receptors in multiple sclerosis pathogenesis.

  2019cites this paper
• Minocycline plus N-acetylcysteine protect oligodendrocytes when first dosed 12 hours after closed head injury in mice.

  2018cites this paper
• 19 Immune System Modulation of Germinal and Parenchymal Neural Progenitor Cells in Physiological and Pathological Conditions

  2018cites this paper
• Distinct patterns of glia repair and remyelination in antibody‐mediated demyelination models of multiple sclerosis and neuromyelitis optica

  2018cites this paper
• P2X4 receptor controls microglia activation and favors remyelination in autoimmune encephalitis

  2018cites this paper
• Animal Models for the Study of Multiple Sclerosis

  2017cites this paper
• Microglia: origins, homeostasis, and roles in myelin repair.

  2017cites this paper
• Microglia support ATF3‐positive neurons following hypoglossal nerve axotomy

  2017cites this paper
• Multipotency and therapeutic potential of NG2 cells.

  2017cites this paper
• Cellular and Molecular Mechanisms Underpinning Macrophage Activation during Remyelination

  2016cites this paper
• Immunology of the Brain

  2016cites this paper
• Cell Injury , Repair , Aging and Apoptosis Fingolimod ( FTY 720 ) Enhances Remyelination Following Demyelination of Organotypic Cerebellar Slices

  2016cites this paper
• Tuftsin‐driven experimental autoimmune encephalomyelitis recovery requires neuropilin‐1

  2016cites this paper
• Immune response in peripheral axons delays disease progression in SOD1G93A mice

  2016cites this paper
• A silver lining of neuroinflammation: Beneficial effects on myelination.

  2016cites this paper
• Regenerative Capacity of Macrophages for Remyelination

  2016cites this paper
• Role of Ion Channels and Activation State in Regulation of Podosomes, Migration and Invasion, and Phagocytosis in Microglia

  2016cites this paper
• Extracellular cues influencing oligodendrocyte differentiation and (re)myelination.

  2016cites this paper
• M1 and M2 immune activation in Parkinson's Disease: Foe and ally?

  2015cites this paper
• Early treatment of minocycline alleviates white matter and cognitive impairments after chronic cerebral hypoperfusion

  2015cites this paper
• Short report Open Access

  2015cites this paper
• Glia Disease and Repair-Remyelination.

  2015cites this paper
• Microglia-Dependent Alteration of Glutamatergic Synaptic Transmission and Plasticity in the Hippocampus during Peripheral Inflammation

  2015cites this paper
• From demyelination to remyelination: The road toward therapies for spinal cord injury

  2015cites this paper
• Fluoxetine Prevents Oligodendrocyte Cell Death by Inhibiting Microglia Activation after Spinal Cord Injury

  2015cites this paper
• Targeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations

  2015cites this paper
• Demyelination as a rational therapeutic target for ischemic or traumatic brain injury.

  2015cites this paper
• Oligodendrocyte‐microglia cross‐talk in the central nervous system

  2014cites this paper
• Mechanisms and pharmacology of neuropathic pain in multiple sclerosis.

  2014cites this paper
• The Experimental Autoimmune Encephalomyelitis Disease Course Is Modulated by Nicotine and Other Cigarette Smoke Components

  2014cites this paper
• Identifying the cellular targets of drug action in the central nervous system following corticosteroid therapy.

  2014cites this paper
• The impact of microglial activation on blood-brain barrier in brain diseases

  2014cites this paper
• Multiple sclerosis, remyelination and the role of fibronectin

  2014cites this paper
• Chronic meningeal inflammation as a cause of cortical grey matter pathology in multiple sclerosis

  2014cites this paper
• Oligodendrogenesis in the normal and pathological central nervous system

  2014cites this paper
• The Neuroprotective Effect of Treatment with Curcumin in Acute Spinal Cord Injury: Laboratory Investigation

  2014cites this paper
• Microglial activation mediates host neuronal survival induced by neural stem cells

  2014cites this paper
• The challenges of respiratory motor system recovery following cervical spinal cord injury.

  2014cites this paper
• From precursors to myelinating oligodendrocytes: contribution of intrinsic and extrinsic factors to white matter plasticity in the adult brain.

  2014influential citation
• Macrophages and CNS remyelination

  2014cites this paper
• Remyelination after spinal cord injury: is it a target for repair?

  2014cites this paper
• MMP‐3 mediates psychosine‐induced globoid cell formation: Implications for leukodystrophy pathology

  2013cites this paper
• GLIAL CELLS RESPONSES: IN OPIOID WITHDRAWAL SYNDROME

  2013cites this paper
• Harnessing monocyte‐derived macrophages to control central nervous system pathologies: no longer ‘if’ but ‘how’

  2013cites this paper
• Dissecting the damaging versus regenerative roles of CNS macrophages: implications for the use of immunomodulatory therapeutics.

  2013cites this paper
• Fibronectin in tissue regeneration: timely disassembly of the scaffold is necessary to complete the build

  2013cites this paper
• Chapter 42 – Animal Models for the Study of Multiple Sclerosis

  2013cites this paper
• Identification of endothelin 2 as an inflammatory factor that promotes central nervous system remyelination.

  2013cites this paper
• The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination.

  2013cites this paper
• The effect of glia-glia interactions on oligodendrocyte precursor cell biology during development and in demyelinating diseases

  2013cites this paper
• Review series on immune responses in neurodegenerative diseases: oligodendrocyte-microglia cross-talk in the central nervous system

  2013cites this paper
• Endogenous Remyelination in the CNS

  2013cites this paper
• Checkpoints in the Development of Pathogenic and Regulatory T Cells in Experimental Autoimmune Encephalomyelitis—A Basis for Current and Future Interventions in MS

  2013cites this paper
• Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone‐induced demyelination

  2013cites this paper
• The Benefits and Detriments of Macrophages/Microglia in Models of Multiple Sclerosis

  2013cites this paper
• Immune System Modulation of Germinal and Parenchymal Neural Progenitor Cells in Physiological and Pathological Conditions

  2012cites this paper
• The Neuroprotective Effect of Treatment of Valproic Acid in Acute Spinal Cord Injury

  2012cites this paper
• Immune surveillance in the central nervous system

  2012cites this paper
• CNS response to a second pro-inflammatory event depends on whether the primary demyelinating lesion is active or resolved.

  2012cites this paper
• Oligodendrocyte-protection and remyelination post-spinal cord injuries: a review.

  2012cites this paper
• Manipulating developmental mechanisms to promote remyelination

  2012cites this paper
• Identification of a microglia phenotype supportive of remyelination

  2012cites this paper
• Imaging of Microglia in Patients with Neurodegenerative Disorders

  2012cites this paper
• Remyelination strategies following spinal cord injury

  2012cites this paper
• Lipopolysaccharide delays demyelination and promotes oligodendrocyte precursor proliferation in the central nervous system.

  2011cites this paper
• The good, the bad and the ugly. Macrophages/microglia with a focus on myelin repair.

  2011cites this paper